Results 171 to 180 of about 8,796,374 (289)

Alteration of subgingival microbiome in patients with type 2 diabetes induced by diabetes treatment

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction Diabetes and periodontal disease, a bacterial infection involving the oral microbiome, have a bidirectional relationship. However, the relationship between poor glycemic control and the oral microbiome remains unclear. The aim of this study was to assess the direct effect of intensive glycemic control on the oral microbiome ...
Moe Inoue   +13 more
wiley   +1 more source

Dietary advanced glycation end products (AGEs) and type 2 diabetes (T2D): a case-control study. [PDF]

open access: yesFront Nutr
Salman Alharbi S   +6 more
europepmc   +1 more source

Effects of esaxerenone add‐on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims Residual albuminuria remains a major clinical challenge in patients with type 2 diabetes mellitus and hypertension despite renin–angiotensin system inhibitor therapy. Esaxerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, reduces albuminuria; however, its effects on oxidative stress remain unclear.
Makoto Ohara   +9 more
wiley   +1 more source

Close relationship between β2‐microglobulin and type 2 diabetes‐associated peripheral neuropathy

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction This study aimed to elucidate the correlation between β2‐microglobulin (β2‐MG) and peripheral neuropathy in type 2 diabetes mellitus (T2DM). Materials and Methods Diabetic peripheral neuropathy (DPN) was defined on the nerve conduction study (NCS).
Jingfang Shao   +3 more
wiley   +1 more source

Effects of Advanced Glycation End Products (AGEs) on Human Lung Macrophages: Implications for Pulmonary Inflammation. [PDF]

open access: yesJ Inflamm Res
Palestra F   +15 more
europepmc   +1 more source

SGLT2i use and fracture risk compared with DPP4i in patients with T2DM

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy after prior dipeptidyl peptidase‐4 inhibitor (DPP4i) use.
Sung‐Yen Lin   +5 more
wiley   +1 more source

Abstract: Perceived Facial Aging: The Role of AGES (Advanced Glycation End Products)

open access: yesPlastic and Reconstructive Surgery, Global Open, 2017
Jonathan Y. Lee, MD, MPH   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy